Release Date: 30/01/09 17:48 Summary: Outcome of EBI General Meeting Price Sensitive: No Download Document 68.29KB Download
MSB Mesoblast resubmits US FDA application for approval of Ryoncil in children with graft vs host disease; shares dip -4%